Encompass Health Prices $500M Senior Notes for Debt Refinancing
EHC sits 15% above its 52-week low of $92.77 on light trading volume (0.4× avg).
Summary
Encompass Health priced a $500 million senior note offering to refinance existing debt and repay revolving credit, extending its debt maturity profile.
Key Events · Financing and Capital Events · EHC
-
$500 Million Senior Notes Offering Priced
The company priced a private offering of $500 million in 5.875% senior notes due 2034, with an issue price of 100% of the principal amount.
-
Debt Refinancing and Repayment
Proceeds will be used to redeem $400 million of outstanding 4.500% Senior Notes due 2028 and repay $100 million of outstanding amounts under the company's revolving credit facility.
-
Extended Debt Maturity
This transaction extends the maturity of a portion of the company's debt from 2028 to 2034, formalizing the offering announced in news on May 14, 2026.
Analysis · EHC · Industrial Applications And Services
Encompass Health has finalized a $500 million private offering of 5.875% senior notes due 2034. The proceeds will be used to redeem $400 million of existing 4.500% senior notes due 2028 and repay $100 million on its revolving credit facility. This transaction extends the maturity profile of a portion of the company's debt, enhancing financial flexibility, though at a higher interest rate compared to the notes being redeemed.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 29.1% of the 1703 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EHC was trading at $106.83 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.6B. The 52-week trading range was $92.77 to $127.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.